• 99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder
  • 99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder
  • 99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder
  • 99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder
  • 99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder
  • 99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder

99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: White Powder
Purity: >99%
Samples:
US$ 50/Bag 1 Bag(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory
Gold Member Since 2021

Suppliers with verified business licenses

Shaanxi, China
Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (10)

Basic Info.

Model NO.
Frazer-Etravirine
Appearance
White Powder
CAS No
269055-15-4
Shelf Life
2 Years
Test Method
HPLC
MOQ
1kg
Storage
Store Cool Dry Place
Resource
Natural
Quality Requirement
Strictly Quality Control
Market
Worldwide
Service
Welcome to Visit Us
Delivery Time
7-10days
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
2500kg/Month

Product Description

99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder

99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical PowderDescription:

Etravirine is a second-generation NNRTI. It is indicated for use in combination with other antiretroviral agents for treating HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to the currently available NNRTIs and other antiretroviral agents. The NNRTIs, along with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), are important components of the combination regimens currently used to treat HIV-1 infection.

Usage:

Etravirine (TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.


99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder
99% Raw Material Etravirine CAS 269055-15-4 Pharmaceutical Powder

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters